Lee Ainslie - Maverick Capital
Holding/activity history for Edwards Lifesciences Corp. (EW)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 29,594 | 0.04 | Buy | 0.04 | $65.99 |
| 2024 Q1 | 0 | 0 | Sell 100.00% | 0.00 | |
| 2023 Q4 | 2,977 | 0.00 | Reduce 43.91% | 0.00 | $76.25 |
| 2023 Q3 | 5,308 | 0.01 | Add 22.93% | 0.00 | $69.33 |
| 2023 Q2 | 4,318 | 0.01 | Reduce 39.46% | 0.01 | $94.26 |
| 2023 Q1 | 7,133 | 0.02 | Add 96.94% | 0.01 | $82.71 |
| 2022 Q4 | 3,622 | 0.01 | Reduce 74.56% | 0.03 | $74.54 |
| 2022 Q3 | 14,238 | 0.03 | Buy | 0.03 | $82.60 |
| 2020 Q4 | 0 | 0 | Sell 100.00% | 0.02 | |
| 2020 Q3 | 15,652 | 0.02 | Reduce 48.75% | 0.02 | $79.80 |
| 2020 Q2 | 30,541 | 0.04 | Buy | 0.04 | $69.12 |
| 2018 Q4 | 0 | 0 | Sell 100.00% | 0.08 | |
| 2018 Q3 | 39,160 | 0.08 | Reduce 61.55% | 0.13 | $174.11 |
| 2018 Q2 | 101,840 | 0.17 | Add 36.13% | 0.05 | $145.57 |
| 2018 Q1 | 74,810 | 0.13 | Reduce 5.85% | 0.01 | $139.51 |
| 2017 Q4 | 79,460 | 0.11 | Add 73.15% | 0.05 | $112.71 |
| 2017 Q3 | 45,890 | 0.06 | Add 36.25% | 0.02 | $109.30 |
| 2017 Q2 | 33,680 | 0.05 | Add 9.03% | 0.00 | $118.23 |
| 2017 Q1 | 30,890 | 0.04 | Reduce 19.64% | 0.01 | $94.08 |
| 2016 Q4 | 38,440 | 0.05 | Add 42.90% | 0.02 | $93.70 |
| 2016 Q3 | 26,900 | 0.04 | Reduce 16.72% | 0.01 | $120.56 |
| 2016 Q2 | 32,300 | 0.04 | Buy | 0.04 | $99.72 |
| 2015 Q3 | 0 | 0 | Sell 100.00% | 0.00 | |
| 2015 Q2 | 3,920 | 0.00 | $71.17 | ||
| 2015 Q1 | 3,920 | 0.00 | Buy | 0.00 | $71.17 |